Cerebrospinal Fluid Biomarkers, Education, Brain Volume, and Future Cognition

Knight Alzheimer’s Disease Research Center, St Louis, MO, USA.
Archives of neurology (Impact Factor: 7.42). 09/2011; 68(9):1145-51. DOI: 10.1001/archneurol.2011.192
Source: PubMed


Cross-sectional studies suggest that the cognitive impact of Alzheimer disease pathology varies depending on education and brain size.
To evaluate the combination of cerebrospinal fluid biomarkers of β-amyloid(42) (Aβ(42)), tau, and phosphorylated tau (ptau(181)) with education and normalized whole-brain volume (nWBV) to predict incident cognitive impairment.
Longitudinal cohort study.
Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri.
A convenience sample of 197 individuals 50 years and older with normal cognition (Clinical Dementia Rating of 0) at baseline observed for a mean of 3.3 years.
Time to Clinical Dementia Rating ≥ 0.5.
Three-factor interactions among the baseline biomarker values, education, and nWBV were found for Cox proportional hazards regression models testing tau (P = .02) and ptau (P = .008). In those with lower tau values, nWBV (hazard ratio [HR], 0.54; 95% confidence interval [CI], 0.31-0.91; P = .02), but not education, was related to time to cognitive impairment. For participants with higher tau values, education interacted with nWBV to predict incident impairment (P = .01). For individuals with lower ptau values, there was no effect of education or nWBV. Education interacted with nWBV to predict incident cognitive impairment in those with higher ptau values (P = .02).
In individuals with normal cognition and higher levels of cerebrospinal fluid tau and ptau at baseline, time to incident cognitive impairment is moderated by education and brain volume as predicted by the cognitive/brain reserve hypothesis.

Download full-text


Available from: Catherine M Roe, Oct 08, 2015
13 Reads
  • Source
    • "We also included a main effect of gender to correct for gender differences between groups. Because education level may influence studies of aging by affecting levels of cognitive reserve (Roe et al., 2011 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Graph theory models can produce simple, biologically informative metrics of the topology of resting-state functional connectivity (FC) networks. However, typical graph theory approaches model FC relationships between regions (nodes) as unweighted edges, complicating their interpretability in studies of disease or aging. We extended existing techniques and constructed fully connected weighted graphs for groups of age-matched human immunodeficiency virus (HIV) positive (n = 67) and HIV negative (n = 77) individuals. We compared test-retest reliability of weighted versus unweighted metrics in an independent study of healthy individuals (n = 22) and found weighted measures to be more stable. We quantified 2 measures of node centrality (closeness centrality and eigenvector centrality) to capture the relative importance of individual nodes. We also quantified 1 measure of graph entropy (diversity) to measure the variability in connection strength (edge weights) at each node. HIV was primarily associated with differences in measures of centrality, and age was primarily associated with differences in diversity. HIV and age were associated with divergent measures when evaluated at the whole graph level, within individual functional networks, and at the level of individual nodes. Graph models may allow us to distinguish previously indistinguishable effects related to HIV and age on FC.
    Neurobiology of Aging 06/2014; 36(1). DOI:10.1016/j.neurobiolaging.2014.06.019 · 5.01 Impact Factor
  • Source
    • "The present study reports on individuals who were primarily middleaged at baseline (mean age, 56.9 years) and have been followed for up to 17 years (mean, 8 years). Third, previous longitudinal studies (Roe et al., 2011a; Yaffe et al., 2011) have used education as a proxy for CR, although education is static and unlikely to change after early adulthood. The present study used a composite measure of CR based on not only education but also literacy and vocabulary, which may change over the lifetime and be a better reflection of CR (Manly et al., 2003, 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The levels of β-amyloid (Aβ) and phosphorylated tau (p-tau), as measured in cerebrospinal fluid, have been associated with the risk of progressing from normal cognition to onset of clinical symptoms during preclinical Alzheimer's disease. We examined whether cognitive reserve (CR) modifies this association. Cerebrospinal fluid was obtained at baseline from 239 participants (mean age, 57.2 years) who had been followed for up to 17 years with clinical and cognitive assessments (mean follow-up, 8 years). A composite score based on the National Adult Reading Test, vocabulary, and years of education at baseline was used as an index of CR. Cox regression models showed that the increased risk of progressing from normal cognition to symptom onset was associated with lower CR, lower baseline Aβ, and higher baseline p-tau. There was no interaction between CR and Aβ, suggesting that the protective effects of higher CR are equivalent across the observed range of amyloid levels. In contrast, both tau and p-tau interacted with CR, indicating that CR was more protective at lower levels of tau and p-tau.
    Neurobiology of aging 08/2013; 34(12). DOI:10.1016/j.neurobiolaging.2013.06.017 · 5.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is growing recognition that the pathophysiological process of Alzheimer disease (AD) begins many years prior to clinically obvious symptoms, and the concept of a presymptomatic or preclinical stage of AD is becoming more widely accepted. Advances in biomarker studies have enabled detection of AD pathology in vivo in clinically normal older individuals. The predictive value of these biomarkers at the individual patient level, however, remains to be elucidated. The ultimate goal of identifying individuals in the preclinical stages of AD is to facilitate early intervention to delay and perhaps even prevent emergence of the clinical syndrome. A number of challenges remain to be overcome before this concept can be validated and translated into clinical practice.
    Nature Reviews Neurology 11/2012; 9(1). DOI:10.1038/nrneurol.2012.241 · 15.36 Impact Factor
Show more